Cosmos Health (COSM) reported preliminary third-quarter 2026 revenue of approximately $17.4 million, a company record for a third quarter. The company also reported preliminary revenue of approximately $54.3 million for the nine months ended September 30, up 19% from $45.6 million a year earlier.
The company reaffirmed its expectation for full-year 2026 revenue to exceed $90 million. Cosmos Health said its third-quarter, nine-month and other 2026 revenue figures are preliminary and unaudited.
- Third-quarter revenue was approximately $17.4 million, compared with $17.1 million in Q3 2025.
- Nine-month revenue totaled approximately $54.3 million, up $8.7 million year over year.
- Revenue for the first nine months represented 83% of the company’s record $65.3 million full-year 2025 revenue.
- Contract manufacturing pipeline at Cana Laboratories exceeded 32.7 million units.
- CosmoFarm distributed products through a network of more than 1,500 pharmacies.
$COSM Insider Trading Activity
$COSM insiders have traded $COSM stock on the open market 5 times in the past 6 months. Of those trades, 5 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $COSM stock by insiders over the last 6 months:
- GRIGORIOS SIOKAS (Chief Executive Officer) has made 4 purchases buying 2,036,003 shares for an estimated $415,000 and 0 sales.
- GEORGIOS TERZIS (Chief Financial Officer) purchased 168,135 shares for an estimated $42,000
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$COSM Hedge Fund Activity
We have seen 9 institutional investors add shares of $COSM stock to their portfolio, and 8 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS GROUP AG added 581,728 shares (+4568.3%) to their portfolio in Q2 2026, for an estimated $107,445
- RENAISSANCE TECHNOLOGIES LLC removed 390,500 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $72,125
- JANE STREET GROUP, LLC added 289,287 shares (+inf%) to their portfolio in Q2 2026, for an estimated $53,431
- HRT FINANCIAL LP removed 67,280 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $12,426
- XTX TOPCO LTD removed 40,477 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $7,476
- GEODE CAPITAL MANAGEMENT, LLC removed 36,017 shares (-11.3%) from their portfolio in Q2 2026, for an estimated $6,652
- SASSICAIA CAPITAL ADVISERS LLC added 36,000 shares (+inf%) to their portfolio in Q2 2026, for an estimated $6,649
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
